Lionel Galicier
Overview
Explore the profile of Lionel Galicier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
5674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larue M, Moulis G, Rueter M, Audia S, Terriou L, Viallard J, et al.
Blood Adv
. 2025 Jan;
PMID: 39874521
To assess efficacy and safety of dapsone in adult immune thrombocytopenia (ITP), a multicenter randomized controlled trial (RCT) and a real-word study cohort were performed. Participants were adults with primary...
2.
Lachmann G, Heeren P, Schuster F, Nyvlt P, Spies C, Feinkohl I, et al.
J Intern Med
. 2025 Jan;
297(3):312-327.
PMID: 39868852
Background: Five fulfilled hemophagocytic lymphohistiocytosis (HLH)-2004 criteria, and the HScore are widely used and recommended by international expert consensus to diagnose secondary HLH. Both diagnostic scores have never been validated...
3.
Cottu A, Guillet S, Viallard J, Riviere E, Cheze S, Gobert D, et al.
Blood
. 2024 Oct;
145(2):244-247.
PMID: 39476101
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained...
4.
Soulard M, Galicier L, Mahlaoui N, Fieschi C, Deshayes S, Gobert D, et al.
Blood Adv
. 2024 Sep;
8(24):6171-6182.
PMID: 39348667
Predominantly antibody deficiencies have an estimated prevalence of >1 in 25 000. Their classical phenotype entails the association of autoimmune manifestations with increased susceptibility to infections. Up to 8% of...
5.
Stammler R, Vacher L, Fournier B, Lemaire P, Chauvel C, Silvestrini M, et al.
J Med Virol
. 2024 Jul;
96(8):e29836.
PMID: 39078052
Primary effusion lymphoma (PEL) is a rare B-cell non-Hodgkin lymphoma associated with Kaposi Sarcoma-associated herpesvirus (KSHV/HHV8) infection. Lymphoma cells are coinfected with Epstein-Barr virus (EBV) in 60-80% of cases. Tools...
6.
Papo M, Haroche J, Sene D, Galicier L, Remy P, Misslin C, et al.
Clin Exp Rheumatol
. 2024 Feb;
42(7):1421-1426.
PMID: 38372716
Objectives: The association of systemic lupus erythematosus (SLE) and human immunodeficiency virus (HIV) remains scarcely described in the literature. Our objectives were to describe the characteristics of SLE in patients...
7.
Launois A, Valade S, Mariotte E, Galicier L, Azoulay E, Roose E, et al.
Res Pract Thromb Haemost
. 2024 Feb;
8(1):102292.
PMID: 38371335
Background: A disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13 (ADAMTS-13) is the specific von Willebrand factor-cleaving protease and circulates in a closed and latent conformation due to...
8.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, et al.
Am J Hematol
. 2023 Jul;
98(9):E259-E262.
PMID: 37410544
No abstract available.
9.
Neuman L, Joseph A, Bouzid R, Lescroart M, Mariotte E, Ederhy S, et al.
J Neurol
. 2023 Jul;
270(10):5023-5033.
PMID: 37392208
Background: The immune form of thrombotic thrombocytopenic purpura (iTTP) and the hemolytic and uremic syndrome (HUS) are two major forms of thrombotic microangiopathy (TMA). Their treatment has been recently greatly...
10.
Sorin B, Fadlallah J, Garzaro M, Vigneron J, Bertinchamp R, Boutboul D, et al.
Ann Hematol
. 2023 Jun;
102(8):2059-2068.
PMID: 37386347
Data on mTOR inhibitors (mTORi) in autoimmune cytopenia (AIC), in adults are scarce. We retrospectively analysed 30 cases of refractory or relapsing AIC treated with an mTORi-based therapy. Eleven warm...